Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Translational Medicine
|
May 12, 2025
Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
Katarzyna Borys, Georg Lodde, Elisabeth Livingstone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
Philipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
Journal of Medical Internet Research
|
July 2, 2026
Extracting Medical Information From Unstructured Clinical Text Using Large Language Models to Enhance Health Care Interoperability: Proof-of-Concept Study
Bahadır Eryılmaz, Kamyar Arzideh, Mikel Bahn, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
Anne Zaremba, Georg Lodde, Rajmohan Murali, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Research Square
|
June 29, 2026
Challenges in AI Based Tumor Board Case Summarization and Recommendations
Wen-Wai Yim, Hendrik Damm, Tabea M G Pakull, et al.
Frontiers in Immunology
|
June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanoma
Johanna Matull, Jan-Malte Placke, Georg Lodde, et al.
Journal of Cancer Research and Clinical Oncology
|
May 14, 2024
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective
Katharina C Kähler, Ralf Gutzmer, Yenny Angela, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Translational Medicine
|
May 12, 2025
Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
Katarzyna Borys, Georg Lodde, Elisabeth Livingstone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
Philipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
Journal of Medical Internet Research
|
July 2, 2026
Extracting Medical Information From Unstructured Clinical Text Using Large Language Models to Enhance Health Care Interoperability: Proof-of-Concept Study
Bahadır Eryılmaz, Kamyar Arzideh, Mikel Bahn, et al.
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
Anne Zaremba, Georg Lodde, Rajmohan Murali, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Research Square
|
June 29, 2026
Challenges in AI Based Tumor Board Case Summarization and Recommendations
Wen-Wai Yim, Hendrik Damm, Tabea M G Pakull, et al.
Frontiers in Immunology
|
June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanoma
Johanna Matull, Jan-Malte Placke, Georg Lodde, et al.
Journal of Cancer Research and Clinical Oncology
|
May 14, 2024
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective
Katharina C Kähler, Ralf Gutzmer, Yenny Angela, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
Page
of 4